Abstract

This article explores the revolutionary landscape of Renal Cell Carcinoma (RCC) management, with a specific focus on the burgeoning field of nano-chemoprevention. As RCC incidence continues to rise, the conventional approaches of surgery, targeted therapies, and immunotherapy are complemented by the innovative strategy of nano-chemoprevention. Leveraging nanotechnology, this approach delivers therapeutic agents at the molecular level, offering targeted and efficient preventive measures that align with the broader shift towards personalized and precision medicine. The potential of nano-chemoprevention to redefine RCC prevention, enhancing efficacy, minimizing side effects, and improving outcomes, is discussed in detail. This article serves as a comprehensive exploration of the transformative impact of nanoparticles in the field of nephrology.